Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of venlafaxine and desvenlafaxine in different metabolizers
NCT00329186Phase 3Completed
- Sponsor
- Pfizer
- Start
- May 2006
- Primary completion
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of desvenlafaxine in major depressive disorder (MDD), sponsored by Pfizer. Started May 2006; status: completed.
02
Drugs
desvenlafaxine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00329186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00329186.